MedCap AB (publ) (STO:MCAP)

Sweden flag Sweden · Delayed Price · Currency is SEK
499.00
+14.00 (2.89%)
Mar 4, 2026, 5:29 PM CET
28.77%
Market Cap 7.28B
Revenue (ttm) 2.11B
Net Income (ttm) 219.80M
Shares Out 15.02M
EPS (ttm) 14.67
PE Ratio 33.07
Forward PE 26.50
Dividend n/a
Ex-Dividend Date n/a
Volume 16,211
Average Volume 20,518
Open 483.00
Previous Close 485.00
Day's Range 482.00 - 499.00
52-Week Range 329.00 - 677.00
Beta 0.52
RSI 47.56
Earnings Date Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 627
Stock Exchange Nasdaq Stockholm
Ticker Symbol MCAP
Full Company Profile

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.64% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Financial Statements

News

What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings

What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings

27 days ago - GuruFocus